US HB2062 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on April 3 2019 - 25% progression, died in committee
Action: 2019-04-04 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 3 2019 - 25% progression, died in committee
Action: 2019-04-04 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
More closely aligns the federal privacy standards for substance use disorder (SUD) patient records with the standards under the Health Insurance Portability and Accountability Act (HIPAA). Specifically, the bill authorizes the disclosure of SUD patient records without a patient's written consent to: (1) a covered entity for the purposes of treatment, payment, and health care operations, as long as the disclosure is made in accordance with HIPAA; and (2) a public health authority, as long as the content of the disclosure meets HIPAA standards regarding de-identified information. Current law authorizes disclosure of SUD patient records without a patient's written consent only to medical personnel in a medical emergency, to specified personnel for research or program evaluations, or pursuant to a court order. The bill also repeals and replaces criminal penalties for certain violations involving SUD patient records with the HIPAA civil penalty structure. It also applies HIPAA criminal penalties to wrongful disclosures of SUD patient records. In addition, the bill expands the current prohibition against using SUD patient records in criminal proceedings to include any use in specified federal, state, and local criminal and civil actions. The bill prohibits certain discrimination based on the release of SUD information under this bill.
Title
Overdose Prevention and Patient Safety Act
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2019-04-04 | House | Referred to the Subcommittee on Health. |
| 2019-04-03 | House | Referred to the House Committee on Energy and Commerce. |
| 2019-04-03 | House | Sponsor introductory remarks on measure. (CR E397) |
| 2019-04-03 | House | Introduced in House |
Same As/Similar To
SB1012 (Related) 2019-04-03 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB3374 (Related) 2020-03-03 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB3374 (Related) 2020-03-03 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Administrative law and regulatory procedures
Criminal investigation, prosecution, interrogation
Department of Health and Human Services
Disability and health-based discrimination
Drug, alcohol, tobacco use
Employment discrimination and employee rights
Evidence and witnesses
Health
Health information and medical records
Housing discrimination
Prescription drugs
Right of privacy
Criminal investigation, prosecution, interrogation
Department of Health and Human Services
Disability and health-based discrimination
Drug, alcohol, tobacco use
Employment discrimination and employee rights
Evidence and witnesses
Health
Health information and medical records
Housing discrimination
Prescription drugs
Right of privacy
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/2062/all-info |
| Text | https://www.congress.gov/116/bills/hr2062/BILLS-116hr2062ih.pdf |
